Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
This study evaluated post-treatment performance and quality of life (QOL) outcome in head and neck cancer (HNC) patients treated with organ preservat ion, intens ive chemoradiotherapy (FHX). Participants were 47 Stage II-IV HNC patients with no evidence of disease at least one year post-completion of organ preservation, concomitant FHX treatment. Patients were assessed via a semi-structured in-person interview, standardized measures of QOL (FACT-H, CES-D), performance (PSS-HN) and patients' perception of residual side effects. Disease, treatment and toxicity data were retrieved from medical charts and protocol records. The most salient performance impairment was inability to eat a normal solid food diet, with 50% of patients able to eat soft foods or take liquids only. This specific functional deficit was not related to global QOL, nor to specific quality of life dimensions. Dry mouth, the most frequent and severe residual effect, was not associated with outcome diet, depression or QOL. Residual pain, seen in only 15% of patients, appeared to influence both functional and QOL parameters as well as being a marker for other troublesome symptoms. Twenty-three per cent of patients were depressed; depression was associated with past problems related to alcohol abuse. Decreased QOL and increased depressive symptomatology were related to total number and severity of residual effects. The data highlight the importance of systematic study of QOL dimensions and caution against making assumptions about patients' experience of particular disease and treatment sequelae.
- Wingo PA, Tong T, Bolden F. Cancer Statistics. CA 1995; 45: 8-30.
- Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and Neck Cancer. N Engl J Med 1993; 328:184-194.
- Vokes EE, Kies M, Haraf DJ, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 1995; 13: 876-883.
- Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993; 85: 95-111.
- Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990; 8: 911-934.
- de Andres L, Brunet J, Lopez Pousa A, et al. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 1995; 10: 822-826.
- Fountzilas G, Kosmidis P, Zamboglou N, et al. Does substitution of surgery with induction chemotherapy preserve organ function in inoperable head and neck cancer? Aretrospective analysis of 73 cases. J Chemother 1994; 6: 672-678.
- Rapoport Y, Kreitler S, Chaitchik S, Algor R, Weissler K. Psychosocial problems in head-and-neck patients and their change with time since diagnosis. Ann Oncol 1993; 4: 69-73.
- Rathmell AJ, Ash DV, Howes M, Nicholls J. Assessing quality of life in patients treated for advanced head and neck cancer. Clin Oncol 1991; 3: 10-16.
- Gamba A, Romano M, Grosso LM, et al. Psychosocial adjustment of patients surgically treated for head and neck cancer. Head & Neck 1992; 14: 218-223.
- Logemann JA, Pauloski BR, Rademaker AW, et al. Speech and swallow function after tonsil/base of tongue resection with primary closure. J Speech Hear Res 1993; 36: 918-926.
- Karim ABMF, Kralendonk JH, Njo KH, Tierie AH, Hasman A. Radiation therapy for advanced (T3T4N0-N3M0) laryngeal carcinoma: The need for a change of strategy: A radiotherapeutic viewpoint. Int J Radiat Oncol Biol Phys 1987; 13: 1625-1633.
- List MA, Ritter-Sterr CA, Baker TM, et al. Longitudinal assessment of quality of life in laryngeal cancer patients. Head & Neck 1996; 18: 1-10.
- Silverman S. Oral cavity toxicity. In: John MJ, Flam MS, Legha SS, Phillips TL, eds. Chemoradiation: An Integrated Approach to Cancer Treatment. Philadelphia, PA(USA): Lea & Febiger, 1993: 511-523.
- Teichgraeber J, Browman J, Goepfert H. Functional analysis of treatment of oral cavity cancer. Arch OtolaryngolHead Neck Surg 1986; 112: 959-965.
- Bjordal K, Kaasa S, Mastekaasa A. Quality of life inpatients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. Int J Oncol Biol Phys 1994; 28: 847-856.
- Breitbart W, Holland JC. Head and neck cancer. In: Holland JC, Rowland JH, eds. Handbook of Psychooncology. New York, NY (USA): Oxford Press, 1989: 232-239.
- Jones E, Lund VJ, Howard DJ, Greenberg MP, McCarthey M. Quality of life of patients treated surgically for head and neck cancer. J Laryngol Otol 1992; 106: 238-242.
- Bjordal K, Kaasa S. Psychological distress in head and neck cancer patients 7–11 years after curative treatment. Br J Cancer 1995; 71: 592-597.
- Harrison LB, Zelefsky MJ, Armstrong JG, et al. Performance status after treatment for squamous cell cancer of the base of tongue—a comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys 1994; 30: 953-957.
- Vokes EE, Haraf DJ, Mick R, McEvilly JM, Weichselbaum RR. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol 1994; 12: 2351-2359.
- Vokes EE, Haraf DJ, Mick R, et al. Concomitant chemoradiotherapy for intermediate stage head and neck cancer (HNC). Proc Am Soc Clin Onc 1994 [Abstract] 13: 282.
- Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutics in cancer. In MacLeod CM, ed. Evaluation of Chemotherapeutic Agents. Symposium, Microbiology Section, New York Academy of Medicine. New York, NY (USA): Columbia University, 1949: 191-205.
- List MA, Ritter-Sterr CA, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-569.
- List MA, D'Antonio LL, Cella DF, et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale: A study of utility and validity. Cancer 1996; 77: 2294-2301.
- Browman GP, Levine MN, Hodson DI, et al. The head and neck radiotherapy questionnaire: amorbidity/quality-of life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 1993; 11: 863-872.
- Cella DF, Tulsky DS, Gray G, et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
- Cella DF. Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (Version 3). Chicago, IL (USA): Rush Medical Center, 1994.
- Radloff LG. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 3: 385-401.
- Karnell MP, MacCracken E, Moran WJ, et al. Swallowing function following multispecialty organ preservation treatment of advanced head and neck cancer. Oncol Rep 1994; 1: 579-601.
- Cella DF, Bonomi AE, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Cancer Therapy - Lung (FACT-L) quality of life instrument. Lung Cancer 1995; 12: 199- 220.
- Rehn LP, Tyndall CI. Mood disorders. In: Sutker PB, Adams HE, eds. Comprehensive Handbook of Psychopathology, Second edition. New York: PlenumPress, 1993: 235-262.
- Baile WB, Gibertini, Scott L, Endicott J. Depression and tumor stage in cancer of the head and neck. Psycho-Oncol 1992; 1: 15-24.
- Nathan PE. Alcoholism: Psychopathology, etiology and treatment. In: Sutker PB, Adams HE, eds. Comprehensive Handbook of Psychopathology, Second Edition ). New York, NY (USA): Plenum Press, 1993: 451- 476.
- Windle M, Miller BA. Alcoholism and depression symptomatology among convicted DWI men and women. J Stud Alcohol 1989; 50: 406-413.
- Westin T, Jannsson A, Zenckert C, HällstrÖm T, EdstrÖm S. Mental depression is associated with malnutrition in patientswith head and neck cancer. Arch Otolaryngol Head Neck Surg 1988; 114: 1449-1453.
- Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer
Quality of Life Research
Volume 6, Issue 3 , p 0
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Head and neck cancer
- performance status
- quality of life
- residual effects
- Industry Sectors
- Author Affiliations
- 1. Department of Medicine, University of Chicago Cancer Research Center, Chicago, USA
- 2. Department of Psychiatry, University of Chicago Cancer Research Center, Chicago, USA
- 3. Department of Radiation and Cellular Oncology, University of Chicago Cancer Research Center, Chicago, USA
- 4. Department of Otolaryngology/Head and Neck Surgery, University of Chicago, 5841 S, Maryland Chicago, USA